France replies to EU objections over its device proposals
This article was originally published in Clinica
The French government is continuing work on a decree to introduce tough new requirements for high-risk medical devices. This is despite opposition from other European member states which has prevented France from enforcing its new requirements before August 5 (see Clinica No 808, p 1).
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.